
|Articles|March 15, 2003
InSite files with FDA for fluoroquinolone approval
Alameda, CA-InSite Vision Inc. has filed an investigational new drug application with the FDA for ISV-403, its treatment for ocular bacterial infections, under development with Bausch & Lomb.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement